All Relations between Stroke and insulin

Publication Sentence Publish Date Extraction Date Species
Renske G Wieberdink, Peter J Koudstaal, Albert Hofman, Jacqueline C M Witteman, Monique M B Breteler, M Arfan Ikra. Insulin resistance and the risk of stroke and stroke subtypes in the nondiabetic elderly. American journal of epidemiology. vol 176. issue 8. 2012-12-31. PMID:23035021. cox regression was used to determine associations between insulin resistance markers and stroke risk, adjusted for age, sex, and potential confounders. 2012-12-31 2023-08-12 human
Renske G Wieberdink, Peter J Koudstaal, Albert Hofman, Jacqueline C M Witteman, Monique M B Breteler, M Arfan Ikra. Insulin resistance and the risk of stroke and stroke subtypes in the nondiabetic elderly. American journal of epidemiology. vol 176. issue 8. 2012-12-31. PMID:23035021. homeostasis model assessment for insulin resistance, which almost perfectly correlated with fasting insulin levels, was also not associated with risk of stroke or stroke subtypes. 2012-12-31 2023-08-12 human
Renske G Wieberdink, Peter J Koudstaal, Albert Hofman, Jacqueline C M Witteman, Monique M B Breteler, M Arfan Ikra. Insulin resistance and the risk of stroke and stroke subtypes in the nondiabetic elderly. American journal of epidemiology. vol 176. issue 8. 2012-12-31. PMID:23035021. in conclusion, in this population-based cohort study among nondiabetic elderly, insulin resistance markers were not associated with risk of stroke or any of its subtypes. 2012-12-31 2023-08-12 human
Andrew M Southerland, Karen C Johnsto. Considering hyperglycemia and thrombolysis in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial. Annals of the New York Academy of Sciences. vol 1268. 2012-12-13. PMID:22994224. considering hyperglycemia and thrombolysis in the stroke hyperglycemia insulin network effort (shine) trial. 2012-12-13 2023-08-12 Not clear
Andrew M Southerland, Karen C Johnsto. Considering hyperglycemia and thrombolysis in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial. Annals of the New York Academy of Sciences. vol 1268. 2012-12-13. PMID:22994224. the stroke hyperglycemia insulin network effort (shine) study is a phase iii single-blinded, randomized control trial comparing an intensive level of glucose control with standard of care glucose control in hyperglycemic stroke patients. 2012-12-13 2023-08-12 Not clear
Charlotte Rosso, Jean-Christophe Corvol, Christine Pires, Sophie Crozier, Yohan Attal, Sophie Jacqueminet, Sandrine Deltour, Gurkan Multlu, Anne Leger, Isabelle Meresse, Christine Payan, Didier Dormont, Yves Samso. Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial. Stroke. vol 43. issue 9. 2012-11-05. PMID:22700528. intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized insulinfarct trial. 2012-11-05 2023-08-12 Not clear
Charlotte Rosso, Jean-Christophe Corvol, Christine Pires, Sophie Crozier, Yohan Attal, Sophie Jacqueminet, Sandrine Deltour, Gurkan Multlu, Anne Leger, Isabelle Meresse, Christine Payan, Didier Dormont, Yves Samso. Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial. Stroke. vol 43. issue 9. 2012-11-05. PMID:22700528. intensive insulin therapy (iit) has not yet proven its efficacy on stroke prognosis or in the reduction of mri infarct growth. 2012-11-05 2023-08-12 Not clear
Charlotte Rosso, Jean-Christophe Corvol, Christine Pires, Sophie Crozier, Yohan Attal, Sophie Jacqueminet, Sandrine Deltour, Gurkan Multlu, Anne Leger, Isabelle Meresse, Christine Payan, Didier Dormont, Yves Samso. Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial. Stroke. vol 43. issue 9. 2012-11-05. PMID:22700528. the insulinfarct study aims at determining in patients with hyperacute stroke whether iit, with a better control of poststroke hyperglycemia, would reduce subsequent mri infarct growth than usual care with subcutaneous insulin. 2012-11-05 2023-08-12 Not clear
Daniel Walcher, Nikolaus Mar. C-Peptide in the vessel wall. The review of diabetic studies : RDS. vol 6. issue 3. 2012-10-02. PMID:20039007. patients with insulin resistance and early type 2 diabetes exhibit an increased sensitivity to develop a diffuse and extensive pattern of arteriosclerosis leading to a remarkable increase in vascular complications, including myocardial infarction and stroke. 2012-10-02 2023-08-12 Not clear
Amytis Towfigh. Insulin resistance, obesity, metabolic syndrome, and lifestyle modification. Continuum (Minneapolis, Minn.). vol 17. issue 6 2ndary Stroke Prevention. 2012-10-02. PMID:22810031. : this article provides an overview of the effects of obesity, metabolic syndrome, and insulin resistance on stroke risk; outlines the association between healthy lifestyle habits and stroke; and summarizes features of effective lifestyle interventions. 2012-10-02 2023-08-12 Not clear
Qiang Xu, Myunghee Cho Paik, Tatjana Rundek, Mitchell S V Elkind, Ralph L Sacc. Reweighting estimators for Cox regression with missing covariate data: analysis of insulin resistance and risk of stroke in the Northern Manhattan Study. Statistics in medicine. vol 30. issue 28. 2012-08-27. PMID:21965165. reweighting estimators for cox regression with missing covariate data: analysis of insulin resistance and risk of stroke in the northern manhattan study. 2012-08-27 2023-08-12 human
Qiang Xu, Myunghee Cho Paik, Tatjana Rundek, Mitchell S V Elkind, Ralph L Sacc. Reweighting estimators for Cox regression with missing covariate data: analysis of insulin resistance and risk of stroke in the Northern Manhattan Study. Statistics in medicine. vol 30. issue 28. 2012-08-27. PMID:21965165. in an analysis of the northern manhattan study (nomas) to determine the influence of insulin resistance on the incidence of stroke in nondiabetic individuals, insulin level is unknown for 34.1% of the subjects. 2012-08-27 2023-08-12 human
Alice S Ryan, Andrew Buscemi, Larry Forrester, Charlene E Hafer-Macko, Frederick M Ive. Atrophy and intramuscular fat in specific muscles of the thigh: associated weakness and hyperinsulinemia in stroke survivors. Neurorehabilitation and neural repair. vol 25. issue 9. 2012-07-30. PMID:21734070. our purpose was to compare muscle volume and muscle attenuation across 6 muscles of the paretic and nonparetic thigh and examine the relationships between intramuscular fat and insulin resistance and between muscle volume and strength in stroke patients. 2012-07-30 2023-08-12 Not clear
Toshio Hayashi, Seinosuke Kawashima, Hideki Nomura, Hideki Itoh, Hiroshi Watanabe, Takashi Ohrui, Koutaro Yokote, Hirohito Sone, Yoshiyuki Hattori, Masao Yoshizumi, Koichiro Ina, Kiyoshi Kubot. Age, gender, insulin and blood glucose control status alter the risk of ischemic heart disease and stroke among elderly diabetic patients. Cardiovascular diabetology. vol 10. 2012-07-03. PMID:21978180. age, gender, insulin and blood glucose control status alter the risk of ischemic heart disease and stroke among elderly diabetic patients. 2012-07-03 2023-08-12 Not clear
Prasad V G Katakam, James A Snipes, Mesia M Steed, David W Busij. Insulin-induced generation of reactive oxygen species and uncoupling of nitric oxide synthase underlie the cerebrovascular insulin resistance in obese rats. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. vol 32. issue 5. 2012-07-03. PMID:22234336. hyperinsulinemia accompanying insulin resistance (ir) is an independent risk factor for stroke. 2012-07-03 2023-08-12 rat
Danielle Sweetnam, Andrew Holmes, Kelly A Tennant, Akram Zamani, Mark Walle, Paul Jones, Charles Wong, Craig E Brow. Diabetes impairs cortical plasticity and functional recovery following ischemic stroke. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 32. issue 15. 2012-06-15. PMID:22496559. diabetic mice also showed persistent behavioral deficits in sensorimotor function of the forepaw, which could not be rescued by chronic insulin therapy after stroke. 2012-06-15 2023-08-12 mouse
Alexandra D Ogorodnikova, Mimi Kim, Aileen P McGinn, Paul Muntner, Unab Khan, Rachel P Wildma. Incident cardiovascular disease events in metabolically benign obese individuals. Obesity (Silver Spring, Md.). vol 20. issue 3. 2012-06-12. PMID:21799477. using pooled data from the atherosclerosis risk in communities and cardiovascular health studies, we assessed incident cvd (coronary heart disease and stroke) using three definitions of the metabolically benign phenotype: (i) the atp-iii metabolic syndrome definition (≤2 of the atp-iii components, excluding abdominal obesity (ii) the expanded atp-iii definition (≤1 of: any atp-iii components, insulin resistance (ir), or systemic inflammation), and (iii) the ir-based definition (sex-specific lowest quartile of the homa(ir) distribution). 2012-06-12 2023-08-12 human
G Ntaios, M Egli, A Arsovska, D Joye, Y Bettex, E Lauber, A Eskandari, S D Ambrogio, B Richoz, J Ruiz, P Miche. An intravenous insulin protocol for strict glycemic control in acute ischaemic stroke. European journal of neurology. vol 19. issue 3. 2012-06-07. PMID:22008406. an intravenous insulin protocol for strict glycemic control in acute ischaemic stroke. 2012-06-07 2023-08-12 Not clear
G Ntaios, M Egli, A Arsovska, D Joye, Y Bettex, E Lauber, A Eskandari, S D Ambrogio, B Richoz, J Ruiz, P Miche. An intravenous insulin protocol for strict glycemic control in acute ischaemic stroke. European journal of neurology. vol 19. issue 3. 2012-06-07. PMID:22008406. we designed an intravenous insulin protocol aiming at rapid and strict glucose control in hyperglycemic ischaemic stroke patients. 2012-06-07 2023-08-12 Not clear
Joanna Hlebowicz, Sandra Lindstedt, Ola Björgell, Magnus Dencke. The effect of endogenously released glucose, insulin, glucagon-like peptide 1, ghrelin on cardiac output, heart rate, stroke volume, and blood pressure. Cardiovascular ultrasound. vol 9. 2012-05-15. PMID:22206473. the effect of endogenously released glucose, insulin, glucagon-like peptide 1, ghrelin on cardiac output, heart rate, stroke volume, and blood pressure. 2012-05-15 2023-08-12 Not clear